期刊文献+

基于JAK/STAT信号通路的高通量药物筛选细胞模型的建立 被引量:5

Establishment of high-throughput drug screening cell models based on JAK-STAT signal pathway
下载PDF
导出
摘要 目的 建立基于JAK STAT信号通路的高通量药物筛选细胞模型 ,筛选调节免疫系统、造血系统和抗肿瘤药物。方法 构建以串连的多个STAT的DNA结合序列为调控序列 ,以荧光酶基因作为报告基因的表达载体。通过将该载体分别转入体外培养的不同细胞系中使之稳定表达 ,建立具有激活STAT活性的药物筛选模型 ,并利用多个抗过敏和抗肿瘤药物样品进行检测。结果 建立多株药物筛选细胞模型 ,筛选方法简便 ,操作容易 ,灵敏度高 ,结果稳定。 Aim To discover new drugs which may be applied to diseases of the immune system, hemogenesis system diseases and tumors, several high-throughput drug screening cell models based on JAK-STAT signal pathway have been established. Methods Four repeats of STAT DNA binding conserved sequences were synthesized, subcloned into pGL-Luc reporter vector and stably transfected into cell lines in vitro . Cell clones with high copy numbers of STAT binding sites and reporter genes were chosen as high-throughput drug screening cell models. The cell models were tested with known anti-allergic drugs and anti-tumor drugs by determining luciferase activity. The reaction was performed in 96 well micro-plates with a final volume of 50 μL. Results The cell models by performing rapid fluorescence assay were shown to be highly sensitive and stable after testing with cytokine and drugs. The modification of the expression plasmid simplified this method and made it more practical. It also provided good linear correlation, wide range of assay, highly sensitive and good reproducibility. Conclusion The method can be performed by high-throughput drug screening for effective extraction of Chinese traditional herbs.
出处 《药学学报》 CAS CSCD 北大核心 2004年第3期164-167,共4页 Acta Pharmaceutica Sinica
基金 863资助项目(2 0 0 2AA2 3 10 3 1) 国家自然科学基金资助项目(3 0 0 70 70 3) 清华大学985项目
关键词 JAK/STAT信号通路 高通量药物筛选细胞模型 模型建立 信号传导 转录激活因子 JAK/STAT high-throughput drug screening cell model
  • 相关文献

参考文献11

  • 1[1]Cur MH. STAT proteins and transcriptional responses to extracellular signals [J]. TIBS, 2000,25(10):496-502.
  • 2[2]Moitreyee CK, Follo VDA, George RS. Association of STATs with relatives and friends [J]. Trend Cell Biology, 2000,10(3):1006-1111.
  • 3[3]Magrassi L, De-Frajia C, Conti L, et al. Expression of the JAK and STAT superfamilies in human meninglinos [J]. J Neurosurg, 1999,91(3):440-446.
  • 4[4]Garcia R, Yu CL, Gudnall A, et al. Constitute activation of Stat3 in fibroblasts transforming diverse oncoproteins and in breast carcinoma cells [J]. Cell Growth Diff, 1996,8(12):1267-1276.
  • 5[5]Melinda H, Carmen P, Kevin R, et al. Constitute activations of STAT3 oncogene product in human ovarian carcinoma cells [J]. Gynecol Oncol, 2000,79(1):67-73.
  • 6[6]Schaefer LK, Menter DG, Schaefer TS, et al. Activation of Stat3 and Stat1 DNA binding and transcription activity in human brain tumor cell lines by gp130 cytokines [J]. Cell Signal, 2000,12(3):143-151.
  • 7[7]Ni J, Lou W, Leman ZS, et al. Inhibition of constitute activated Stat3 signaling pathway suppresses growth of prostate cancer cells [J]. Cancer Res, 2000,60(5):1225-1228.
  • 8[8]Ohmori Y, Gamilton TA. IL-4 induced STAT6 suppresses IFN-γ stimulated STAT1 dependent transcription in mouse macrophages [J]. J Immunol, 1997,(159):5474-5482.
  • 9[9]Girdlestone J, Wing M. Autocrine activation by interferon-gramma of STAT factors following T cell activation [J]. Eur J Immunol, 1996,26(3):704-709.
  • 10[10]Ranshoff RM. Cellular responses to interferons and other cytokines: the JAK-STAT paradigm [J]. N Engl J Med, 1998,338(9):616-618.

同被引文献27

  • 1郭峰,刘彦信,郑德先,蒋澄宇.维甲酸受体为靶点的高通量药物筛选细胞模型的建立[J].药学学报,2005,40(10):908-911. 被引量:3
  • 2Ivashkiv LB, Hu X. Signaling by STATs [ J]. Arthritis Res Ther, 2004, 6(4) :159-168.
  • 3Benekli M, Baer M R, Baumann H, et al. Signal transducer and activator of transcription proteins in leukemias[ J]. Blood, 2003, 1111 ( 8 ) :2940-2954.
  • 4Nikol' skii N N, Vasilenko K P. STAT Pathway of intracellular signaling[ J]. Zh Evol B iochim Fiziol, 2000, 36 (6) : 504-508.
  • 5Kostanian I A, Vonarshenko A V, Lipkin V M. STATI: A many-sided transcription factor[ J ]. Bioorg Khim, 2010, 36 (1) :15-28.
  • 6Yoshimura A. Signal transduction of inflammatory cytokines and tumor development [J]. Cancer Sci, 2006, 97(6) :439-447.
  • 7Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3 [ J ]. Nat Rev Cancer, 2009, 9( 11 ) :798-809.
  • 8Ortmann R A, Cheng T, Visconti R, et al. Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation [ J ]. Arthritis Res, 2000, 2( 1 ):16-32.
  • 9Fan F, Wood K V. Bioluminescent assays for high-throughput screening [ J ]. Assay Drug Dev Technol, 2007, 5 ( 1 ) : 127-136.
  • 10Naylo L H. Reporter gene technology: The future looks bright [ J ]. Biochem Pharmacol, 1999,58 (5) : 749-757.

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部